INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND CHEMICAL SCIENCES

Similar documents
ASSAY AND IMPURITY METHOD FOR DURACOR TABLETS BY HPLC

Research Article Simultaneous Estimation of DL-Methionine and Pyridoxine Hydrochloride in Tablet Dosage Form by RP-HPLC

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

International Journal of Pharma and Bio Sciences DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF STRONTIUM RANELATE IN SACHET

A simple validated RP-HPLC method for quantification of sumatriptan succinate in bulk and pharmaceutical dosage form

A New Stability-Indicating and Validated RP-HPLC Method for the Estimation of Liraglutide in Bulk and Pharmaceutical Dosage Forms

ANALYTICAL TECHNIQUES FOR THE QUALITY OF ANTI- AIDS DRUGS

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ESTIMATION OF LACOSAMIDE IN BULK AND ITS PHARMACEUTICAL FORMULATION

Pelagia Research Library

CHAPTER 2 SIMULTANEOUS DETRMINATION OF ANASTROZOLE AND TEMOZOLOMIDE TEMOZOLOMIDE CAPSULES 20 MG AND ANASTROZOLE TABLETS 1 MG

Accelerated Stability Studies on Valacyclovir Hydrochloride by RP-HPLC

METHOD DEVELOPMENT AND VALIDATION BY RP-HPLC FOR ESTIMATION OF ZOLPIDEM TARTARATE

AMERICAN JOURNAL OF BIOLOGICAL AND PHARMACEUTICAL RESEARCH

Simultaneous estimation of Rabeprazole and Mosapride by RP-HPLC method in tablet dosage form

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD ESTIMATION OF TOLVAPTAN IN BULK PHARMACEUTICAL FORMULATION

Journal of Chemical and Pharmaceutical Research, 2013, 5(1): Research Article

Airo International Research Journal ISSN : Volume : 7 October 2015

Volume 2 (6), 2014, Page CODEN (USA)-IJPRUR, e-issn: International Journal of Pharma Research and Health Sciences

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS OF TRAMADOL IN PURE AND PHARMACEUTICAL FORMULATIONS

RP-HPLC Method Development and Validation of Abacavir Sulphate in Bulk and Tablet Dosage Form

Method Development and Validation for the Estimation of Saroglitazar in Bulk and Pharmaceutical Dosage Form by RP-HPLC

Research Article Derivative Spectrophotometric Method for Estimation of Metformin Hydrochloride in Bulk Drug and Dosage Form

Development and validation of stability indicating RP-LC method for estimation of calcium dobesilate in pharmaceutical formulations

Comparison of conventional HPLC with UPLC method for determination of albuterol sulfate and it s impurities in pharmaceutical formulation

J Pharm Sci Bioscientific Res (4): ISSN NO

Isocratic Reversed Phase Liquid Chromatographic Method Validation for the Determination of Cilostazol in Pure and Formulations

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

NOVEL RP-HPLC METHOD. B.Lakshmi et a. concentration range KEY INTRODUCTION. Diltiazem is used to. . It works by of contractionn of the. (dilate).

METHOD DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR DETERMINATION OF NEW ANTIDIABETIC AGENT LINAGLIPTIN IN BULK AND IN PHARMACEUTICAL FORMULATION

A Validated Stability Indicating RP-HPLC Method for Simultaneous Estimation of Valsartan and Clinidipine Combined Tablet dosage forms

ISSN: ; CODEN ECJHAO E-Journal of Chemistry 2011, 8(3),

Development and Validation for Simultaneous Estimation of Sitagliptin and Metformin in Pharmaceutical Dosage Form using RP-HPLC Method

International Journal of Medicine and Pharmaceutical Research. International Journal of Medicine and Pharmaceutical Research

World Journal of Pharmaceutical Research

RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF BACLOFEN IN BULK AND PHARMACEUTICAL DOSAGE FORMS

Journal of Pharmacreations

Journal of Chemical and Pharmaceutical Research

Research Article DEVOLOPMENT OF RP-HPLC METHOD AND IT S VALIDATION FOR SIMULTANEOUS ESTIMATION OF SITAGLIPTIN AND METFORMIN

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

Pelagia Research Library

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS TOLBUTAMIDE IN PURE AND PHARMACEUTICAL FORMULATIONS

Stability Study of Hydralazine HCl Oral Solutions Compounded in Humco Oral Vehicles to Determine a Beyond-use Date

International Journal of Innovative Pharmaceutical Sciences and Research

Abstract. G. D. Patil 1, P. G. Yeole 1, Manisha Puranik 1 and S. J. Wadher 1 *

Simultaneous Estimation of Gemcitabine Hydrochloride and Capecitabine Hydrochloride in Combined Tablet Dosage Form by RP-HPLC Method

Method Development and Validation for Simultaneous Estimation of Atorvastatin and Ezetimibe in Pharmaceutical Dosage Form by HPLC

International Journal of Pharma and Bio Sciences

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

F. Al-Rimawi* Faculty of Science and Technology, Al-Quds University, P.O. Box 20002, East Jerusalem. Abstract

Stability indicating RP-HPLC method development and validation of Etizolam and Propranolol hydrochloride in pharmaceutical dosage form

HYDROLYTIC DEGRADATION PROFILING OF EZETIMIBE BY HPLC METHOD

Validation of Developed Analytical Method for Balofloxacin Floating Tablets by Reverse Phase High Performance Liquid Chromatography

RP-HPLC Analysis of Temozolomide in Pharmaceutical Dosage Forms

MEDAK DIST. ANDHRA PRADESH STATE, INDIA. Research Article RECEIVED ON ACCEPTED ON

Simultaneous estimation of Metformin HCl and Sitagliptin in drug substance and drug products by RP-HPLC method

Journal of Chemical and Pharmaceutical Research, 2017, 9(9): Research Article

Available online at Scholars Research Library

Development and Validation of a Simultaneous HPLC Method for Quantification of Amlodipine Besylate and Metoprolol Tartrate in Tablets

36 J App Pharm Vol. 6; Issue 1: 36-42; January, 2014 Rao et al., 2014

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

Available online Research Article

6.02 Uniformity of Dosage Units

IJPAR Vol.3 Issue 4 Oct-Dec-2014 Journal Home page:

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

S. G. Talele, D. V. Derle. Department of Pharmaceutics, N.D.M.V.P. College of Pharmacy, Nashik, Maharashtra, India

Estimation of Zanamivir Drug present in Tablets using RP-HPLC Method

Development and Validation of RP-HPLC Method for the Estimation of Gemigliptin

Development and validation of spectrophotometric method for simultaneous estimation of Sumatriptan and Naproxen sodium in tablet dosage form

A New RP-HPLC Method for the Simultaneous Estimation of Naltrexone Hydrochloride and Bupropion in Its Pure and Pharmaceutical Dosage Form

VALIDATED RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF DEXAMETHASONE AND GRANISETRON IN COMBINED DOSAGE FORMS

Analytical Method Development and Validation for the Estimation of Guaifenesin and Dextromethorphan by RP-HPLC

Estimation of zolmitriptan by a new RP-HPLC method

Journal of Chemical and Pharmaceutical Research, 2018, 10(3): Research Article

The Nitrofurantoin Capsules Revision Bulletin supersedes the currently official monograph.

Research Article. ISSN Available online at 746

Validation of Changes to the USP Assay Method for Ibuprofen Tablets

This revision also necessitates a change in the table numbering in the test for Organic Impurities.

Scholars Research Library. Der Pharmacia Lettre, 2015, 7 (5):44-49 (

Application Note. Agilent Application Solution Analysis of ascorbic acid, citric acid and benzoic acid in orange juice. Author. Abstract.

New RP-HPLC Method for the Determination of Fludarabine in Pharmaceutical Dosage Forms

(ACE) inhibitor class that is primarily used in cardiovascular. conditions. Lisinopril was introduced into therapy in the early

Development and Validation of a UV-Spectrophotometric Method for Quantification of Atorvastatin in Tablets

Scholars Research Library

Development, Estimation and Validation of Lisinopril in Bulk and its Pharmaceutical Formulation by HPLC Method

Ankit et al Journal of Drug Delivery & Therapeutics; 2013, 3(2), Available online at RESEARCH ARTICLE

A stability indicating RP-HPLC method for simultaneous estimation of darunavir and cobicistat in bulk and tablet dosage form

Stability of Captopril in an Extemporaneously Compounded Humco s Oral Products

RP-HPLC Method for the Simultaneous Estimation of Sitagliptin Phosphate and Metformin Hydrochloride in Combined Tablet Dosage Forms

A HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC ASSAY FOR LERCANIDIPINE HYDROCHLORIDE

Volume 6, Issue 1, January February 2011; Article-021

Method Development And Validation Of Losartan Potassium And Hydrochlorothiazide In Comined Dosage Form By RP-HPLC

RP- HPLC and Visible Spectrophotometric methods for the Estimation of Meropenem in Pure and Pharmaceutical Formulations

HPTLC Determination of Atomoxetine Hydrochloride from its Bulk Drug and Pharmaceutical Preparations

Title Revision n date

SIMULTANEOUS QUANTIFICATION OF TELMISARTAN AND METOPROLOL SUCCINATE IN TABLETS BY LIQUID CHROMATOGRAPHY

Validated UV Spectrophotometric Method Development And Stability Studies Of Acamprosate Calcium In Bulk And Tablet Dosage Form

Validated RP-HPLC Method for the Estimation of Esomeprazole Enteric Coated Tablets

Estimation of Emtricitabine in Tablet Dosage Form by RP-HPLC

SIMULTANEOUS DETERMINATION OF ATORVASTATIN AND EZETIMIBE BY RP-HPLC IN PURE AND PHARMACEUTICAL DOSAGE FORM

Pankti M. Shah et al, Asian Journal of Pharmaceutical Technology & Innovation, 04 (17); 2016; 07-16

Transcription:

Research Article Stabilization of Folic Acid in Liquid Dosage Form: Formulation Development, Method Validation and Comparative Analysis Vignesh M 1, Sivakumar M 2, Parkavi V* 1, Selvakumar K 1 and Joysa Ruby J 1 1 Faculty of Pharmacy, Masterskill University College of Health Sciences, Cheras, Selangor, Malaysia. 2 School of Chemical & Environmental Engineering, University of Nottingham, 43500 Semenyih, Selangor, Malaysia. ABSTRACT Vitamins are essential nutrients available as multivitamin combinations. The stability of individual vitamins remains a question since most of the vitamins are decomposed during storage. Folic acid is a water soluble vitamin and found to be unstable in the presence of water and also other vitamins. Due to this stability problem, this vitamin is not available alone in liquid dosage forms. This problem is mainly attributed to the change in ph. So, the present investigation aims to provide a stable liquid preparation of folic acid alone by the usage of suitable solvents and stabilizers in order to maintain the ph. Stability study has been conducted to find out the degradation rate and the shelf-life of formulation has also been determined. The obtained results have been compared with three different innovators multivitamin products containing the folic acid. The experimental studies clearly show that a stable ph range between 5 and 5.5 for folic acid could be maintained very well by using the mixed solvents of sorbitol, glycerine and propylene glycol and the degradation rate has been found to be significantly less in the present formulation as compared with innovator products. For the analysis of folic acid, High Performance Liquid Chromatography method has also been developed, optimized and validated for its precision, accuracy and specificity. The data obtained indicate the suitability of this High Performance Liquid Chromatography method for the analysis of folic acid. This report is the first of its kind in dealing with the stabilization of folic acid in liquid dosage form. Keywords: folic acid, stabilization, formulation, validation, liquid dosage form. 1.0. INTRODUCTION Formulation and stability problems arise more frequently with liquid pharmaceutical preparations than solid dosage forms, and for this reason many new drugs first reach the market as tablets or dry-filled capsules. Later, when the pharmaceutical problems are resolved, a liquid form of the same drug is generally marketed. Among the various liquid preparations, oral liquids are homogeneous preparations containing one or more active ingredients in a suitable vehicle. Multivitamin preparations are available in liquid formulations like syrups, suspensions, and elixirs. In these preparations, vitamins are known to lose their potency during storage even though most of the individual vitamins are stable and many are prepared into reasonably stable dosage forms by themselves 1. Loss of vitamin activity in premixes and complete feeds during storage may account for hidden depressions in growth, feed efficiency and disease resistance due to sub clinical vitamin deficiencies 2. Unfortunately, many vitamins are relatively unstable compounds and undergo significant deterioration under normal storage conditions. Some of the factors that are generally responsible for the instability of vitamins in multivitamin preparations are the ph of the medium, the presence of certain minerals like iron, copper, calcium, etc., and the concentration of water present in the preparation, the conditions of storage such as light, atmospheric oxygen, Vol. 1 (1) Jan Mar 2012 www.ijpcsonline.com 332

temperature, etc. 3 and the incompatibility between vitamins. Folic acid is available in multivitamin combinations in liquid formulations but it is not available alone in liquid dosage form due to its instability. Looking at this important problem, the present investigation aims to formulate, stabilize and thereby provide a liquid formulation for the oral delivery of folic acid alone and to stabilize the preparation against all the destabilizing factors as mentioned above. Basically, folic acid is stable in aqueous solutions 4 of ph in between 5 and 8. Thus, the present study of folic acid stability in liquid formulation is aimed with the help of laboratory solvents and stabilizers. 2.0. EXPERIMENT 2.1. MATERIALS Folic acid was obtained from Sri Krishna drugs, Chennai, India. Glycerine, Sorbitol solution and Propylene glycol were supplied from Pan Century, Malaysia, Gulshan polyols and Manali petrochemicals, Chennai, India respectively. All the solutions and reagents were of pharmaceutical and analytical grade. 2.2. PREFORMULATION STUDIES The preformulation studies 5 have been conducted in five divided stages, which include studies on purified water, sorbitol solution, glycerine, propylene glycol and sugar solution 50 % which were used as solvents and/or co-solvents for the solubility and stability of folic acid. 3.0. RESULTS AND DISCUSSION 3.1. ph and Determination of amount of folic acid in individual solvents The ph and amount of folic acid were determined in the preformulation. The ph was determined using ph meter and the amount of folic acid was estimated using High Performance Liquid Chromatography technique 6. The analysis was made during the initial day, 15 th day and after 30 th day of storage. Table I: ph and the amount of folic acid in various preformulations S.No. Test Solution Initial Day 15 th Day 30 th Day ph (%) ph (%) ph (%) 1. Folic acid (20mg) solution + Purified water 5.33 99.35 7.34 19.26 8.48 8.86 2. Folic acid (20mg) solution + Sorbitol solution 5.35 99.97 5.33 94.6 5.32 93.09 3. Folic acid (20mg) solution + Glycerine 5.36 99.21 5.38 94.34 5.39 92.03 4. Folic acid (20mg) solution + Propylene glycol 5.37 99.06 5.36 95.75 5.35 94.08 5. Folic acid (20mg) solution + Sugar solution 5.33 98.34 4.98 67.17 4.06 9.78 From the above results, it could be observed that the ph range in between 5 and 5.5 was maintained by using sorbitol solution, glycerine and propylene glycol, but the ph was increased in purified water, whereas it was decreased in sugar solution. In addition, turbidities were also found in sugar solution as well as in purified water after 15 and 30 days respectively. In assay, folic acid was stable and stability was found to be high in sorbitol solution, glycerine and propylene glycol except purified water and sugar solution, which was well correlated with ph. Thus, sorbitol solution, glycerine and propylene glycol were taken for further studies. 3.2. ph and Determination of amount of folic acid in combined solvents The sorbitol solution, glycerine and propylene glycol were combined together with folic acid at the same concentration and determined for ph and content of folic acid in every 15 days intervals. Vol. 1 (1) Jan Mar 2012 www.ijpcsonline.com 333

S.No. 1. Table II: ph and the amount of folic acid in the combined solvents Initial Day 15 th Day 30 th Day Test Solution ph (%) ph (%) ph (%) Folic acid (20mg) solution + Sorbitol solution + Glycerine 5.34 99.97 5.35 95.92 5.35 94.78 + Propylene glycol Based on the above observations, it could be seen that the ph range in between 5 and 5.5 was maintained in the presence of combined solvents, i.e. sorbitol solution, glycerine and propylene glycol with folic acid. This supports that the folic acid is stable in the above combination and due to this the same solvents has been considered for the formulation development. 3.3. ANALYTICAL METHOD DEVELOPMENT AND OPTIMIZATION OF CHROMATOGRAPHIC CONDITIONS Based on the optimization studies, the chromatographic parameters for the estimation of folic acid was as follows: Instrument setup -Isocratic; Column - Waters Symmetry 250 x 4.6 mm, 5 µm; Detection wavelength - 280 nm; Mobile phase - Methanol : Water : 1-Hexane sulfonic acid sodium salt in 30:70:0.15 and the ph was adjusted to 3.0 using orthophosphoric acid; Diluents - Dipotassium hydrogen orthophosphate (0.57 % in water) adjusted to ph 7.0 using orthophosphoric acid; Injection volume - 20 µl; Flow rate - 1.0 ml/min; Temperature - Ambient temperature; Run time - 10 min. 3.3.1. HPLC ANALYSIS 3.3.1.1. Preparation of working standard solution Weighed accurately 20 mg of folic acid working standard, transferred into a 50 ml volumetric flask, dissolved and made up to the volume using the diluent. Further, 5 ml of standard stock solution was diluted to 100 ml with diluent, which was mixed well and filtered using Millipore filter (20 ppm). 3.3.1.2. Preparation of test solution Each 2 ml of sorbitol solution, glycerine and propylene glycol was pipetted out, transferred into a 50 ml volumetric flask, dissolved and made up to the volume using the diluent, which was then mixed well and filtered using Millipore filter (20 ppm). The content of folic acid was estimated in the test solution using HPLC technique and percentage content was determined. 3.3.2. HPLC METHOD VALIDATION Following analytical method validation 7, 8, 9 parameters were studied; system suitability, similarity factor, specificity, linearity & range, precision (repeatability) and accuracy. (A) System Suitability Parameter Table III: System Suitability No. of replications % RSD of Rt % RSD of area (B) Similarity Factor Acceptance criteria of % RSD System suitability 6 0.7 0.7 < 2.0 Parameter Table IV: Similarity Factor No. of replications Result obtained Acceptance criteria Similarity factor 2 + 2 1.02 1 + 0.1 Vol. 1 (1) Jan Mar 2012 www.ijpcsonline.com 334

(C) Specificity (D) Linearity and Range There was no interference with blank, A plot was made using area vs placebo and in the retention time of folic concentration and the value of R 2 was acid and thus this method was specific. found to be 0.999. This clearly proves that the method was linear over the concentration range studied and within the specified limit. (E) Method Precision Table V: Method Precision % RSD % Content Parameter Acceptance Rt Area criteria Assay Input Method precision 1.2 0.8 2.0 97.78 100.0 (F) Accuracy Table VI: Accuracy Assay (μg) % Recovery Parameter Std Wt Quantity Acceptance Obtained taken found criteria Accuracy solution - 1 10.1 9.97 98.71 Accuracy solution -2 20.2 20.24 100.19 98.0 102.0 Accuracy solution - 3 30.3 29.77 98.25 The above method validation showed that the reported values were found to be within the acceptance criteria. So, this method was valid and thus could be implemented for further studies. 3.4. FORMULATION 3.4.1. Preparation of Folic Acid Solution Folic acid 20 mg was weighed accurately into a clean and dried beaker. To this freshly prepared sodium hydroxide 10, 11 solution was added dropwise and was stirred well with a glass rod until it dissolves completely. Propylene glycol was weighed and poured into the above solution followed by glycerine with continuous stirring (Solution-I). Sorbitol was weighed and poured into that mixture and stirred well (Solution-II). Solution-II was added slowly into solution-i and mixed well with constant and continuous stirring. Methyl paraben and propyl paraben were added and act as a preservative. It was then filtered with muslin cloth; the strawberry flavor was added and transferred into a measuring cylinder, made up to the volume using purified water. This final solution was stored in an amber colored bottle and labeled after adjusting the ph to 5.31. 3.4.2. Observation A clear, optimum viscous, yellowish colored, sweetened, flavored folic acid liquid was found and the ph was observed to be 5.31. This trial batch was analysed by HPLC and ph was periodically checked. The HPLC results and a stable ph clearly indicate an improvement of the developed formulation. Thus, the exact formula for this formulation have been achieved. After this, the formulation was analysed as per ICH guidelines and stability studies were performed. 3.5. STABILITY STUDIES The accelerated stability study was conducted as per ICH guidelines at an accelerated temperature of 40+2 o C / 75+5 % RH and long term stability studies were conducted at a room temperature of 25+2 o C / 60+5 % RH for two years at periodic intervals. The shelf life of folic acid has been predicted by using the graphical method 12. The results as shown in Table 7 and Fig.1 indicate the stability Vol. 1 (1) Jan Mar 2012 www.ijpcsonline.com 335

maintained in the product at the periodic time intervals. Storage condition 25+2 o C / 60+5 % RH 40+2 o C / 75+5 % RH Table VII: Stability studies for the formulated folic acid liquid Wt. of working Assay Months Description std folic acid Label claim Obtained ph (mg) (μg) μg % 0 20.0 5.31 500 492.10 98.42 1 st 20.0 5.34 500 425.00 96.11 2 nd 20.0 5.36 500 478.70 95.74 3 rd 20.0 5.37 500 470.00 94.00 4 th 20.0 5.37 500 466.15 93.23 5 th 20.0 5.38 500 455.90 91.18 6 th 20.0 5.38 500 452.8 90.56 9 th 20.0 5.39 500 441.5 88.30 12 th A clear, viscous, 20.0 5.39 500 434.05 86.81 18 th yellowish 20.0 5.40 500 421.40 84.28 colored, flavored 24 th folic acid liquid 20.0 5.41 500 413.75 82.75 0 20.0 5.31 500 492.10 98.42 3 rd 20.0 5.36 500 464.70 92.94 6 th 20.0 5.37 500 428.05 85.61 Fig.1: Stability studies at room temperature 3.5.1. Prediction of Shelf-Life from Stability Data This accelerated stability testing is useful in providing the information from which to assess the probable stability of a new product but it should be conducted in conjunction with long-term stability studies at the maximum recommended storage temperature for the duration of the nominated shelf-life. The possible shelflife of the present formulation was obtained using the long term stability studies for two years as shown in Fig. 1. 3.5.2. Comparative Analysis with Innovator Products Among the innovator products of multivitamin combination of folic acid in liquid formulation, three of them have been selected for this study as shown in Table 8. The innovator products had been analyzed accordingly as per the analytical procedure followed in the present study and the percentage content of folic acid was determined in these preparations compared with our formulation at the room temperature storage condition. Vol. 1 (1) Jan Mar 2012 www.ijpcsonline.com 336

SI. No. 1. 2. 3. 4. Name of the Product Present Folic Acid liquid formulation Multivitamin liquid product - I Multivitamin liquid product - II Multivitamin liquid product - III Table VIII: Comparative data of innovator products Storage Condition 25+2 o C / 60+5 % RH Description Month of Analysis ph % content of Folic acid A clear, optimum viscous, yellowish colored, sweetened, flavored liquid 24 th 5.41 82.75 A viscous, dark brown colored, flavored liquid 24 th 5.83 51.25 A viscous, very dark blackish colored, flavored liquid 24 th 6.03 47.95 A viscous, dark brown colored, flavored liquid 24 th 6.33 38.45 Fig.2: Comparative analysis with innovator products At room temperature (25+2 o C /60+5 % RH), the present folic acid liquid formulation has been compared with that of 3 different innovator products. The percentage content and stability of folic acid has been found to be good in the present formulation, whereas the content was found to be very less in the innovator products. Based on the above observations, the ph ranges and folic acid stability was determined. When compared to marketed products, the present formulation was found to be stable. 4.0. CONCLUSIONS The present investigation has provided a stable liquid preparation of folic acid in the combined solvents of sorbitol solution, glycerine and propylene glycol with stabilizers. The ph of the said preparation has been adjusted and maintained in between 5 and 5.5. This formulation was stable with no significant degradation even when the liquid preparation was stored for 2 years at room temperature. From the stability data, it has been observed that the folic acid degradation rate was drastically increased due to the presence of water in the formulation. Replacement of this water by sorbitol solution, glycerine and propylene glycol significantly improved the folic acid stability in liquid formulation, which was indicated by the high percentage of folic acid in the present formulation compared to innovator products. 5.0. ACKNOWLEDGEMENTS The authors are thankful to the team of our study and those who involved passively for support in all the aspects to complete this research activity. 6.0. REFERENCES 1) The Pharmaceutical Codex Principles and practice of Pharmaceutics (1994) 12 th Edn; 31:189. Vol. 1 (1) Jan Mar 2012 www.ijpcsonline.com 337

2) Coelho M.Fate of Vitamins in Premixes and Feeds: Vitamin Stability. Feed Management. (1991);42(10):24. 3) Akhtar M.J, Khan M.A, Ahmad I; Photodegradation of folic acid in aqueous solution. J. Pharma Biomed Anal. 1999;19(3):269-275. 4) Manzur Ul and Haque Hashmi. Assay of Vitamins in Pharmaceutical Preparations (1972) 1 st Edn; 7(10): 213-226. 5) Howard C Ansel, Loyd V Allen and Nicholas G Popovich. Pharmaceutical Dosage Forms and Drug Delivery Systems (2000) 7 th Edn; 38, 64. 6) Ekinci R and Kadakal C. Determination of seven watersoluble vitamins in Tarhana, a traditional Turkish cereal food, by High-Performance Liquid Chromatography. Acta Chromatographica. 2005;15:289-297. 7) Sethi P D; High Performance Liquid Chromatography.2001; 1 st Edn; 116-20. 8) United States Pharmacopoeia 28 / NF 23 2005; 748-2751. 9) ICH Harmonised tripartite guideline; Validation of analytical procedures: Methodology-Q2A.2005; 10(11):1-10. 10) Kohli DPS, Shah DH. Drug Formulations Manual. 2001;134-35. 11) Deshpande S W, Nilesh Gandhi; Drugs and Cosmetics Act 1940 and Rules 1945 (2000); 2 nd Edn; 538-39. 12) ICH Harmonised tripartite guideline; Stability testing of new drug substances and products- Q1A (R2) (2003);6 (2):3-5. Vol. 1 (1) Jan Mar 2012 www.ijpcsonline.com 338